Nonprofit drugmaker Civica Rx unveils plans for insulin biosimilars, $30 per vial March 3, 2022 Auto Bot BioPharma, biopharma nl, diabetes, drug prices, insulin, News, Pharma, Utah 0 Civica Rx plans to make lower cost versions of three branded insulin products, biosimilars that are expected to reach the market in 2024. In addition to $30 vials, Civica plans to sell pen cartridges at $55 for a box of five.